Ventavis Approval History
- FDA approved: Yes (First approved December 29th, 2004)
- Brand name: Ventavis
- Generic name: iloprost
- Dosage form: Inhalation Solution
- Company: CoTherix, Inc.
- Treatment for: Pulmonary Hypertension
Ventavis (iloprost) inhalation solution is synthetic analogue of prostacyclin PGIB2B indicated for the treatment of pulmonary arterial hypertension.
Development History and FDA Approval Process for Ventavis
|Dec 29, 2004||Ventavis CoTherix, Inc. - Treatment for Pulmonary Arterial Hypertension|
|Sep 8, 2004||CoTherix, Inc. Announces Priority Review Designation by the FDA for Ventavis NDA|
|Jul 1, 2004||CoTherix, Inc. Announces Filing of Ventavis NDA|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.